Organisation paid for research Program year 2025 Source: CMS Open Payments

Be Well Memory and Infusion

Neither a doctor nor a teaching hospital

Research payments

$52,034

24 payments

Through program year 2025, Be Well Memory and Infusion is reported as receiving $52,034 in research payments, across 24 payments.

By program year

1 row
Year Kind Amount Payments
2025 Research $52,034 24

Breakdown

Who paid Research payments · program year 2025
  1. Boehringer Ingelheim International GmbH $40,349 21 payments
  2. Boehringer Ingelheim Pharma GmbH & Co.KG $11,685 3 payments
Studies the money was for Research payments · program year 2025
  1. EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) < 40% $52,034 24 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record